title: Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
authors.forename: Niels W C J
authors.initials: NW
authors.lastname: van de Donk
authors.forename: Nicolaus
authors.initials: N
authors.lastname: Kröger
authors.forename: Ute
authors.initials: U
authors.lastname: Hegenbart
authors.forename: Paolo
authors.initials: P
authors.lastname: Corradini
authors.forename: Jesus F
authors.initials: JF
authors.lastname: San Miguel
authors.forename: Hartmut
authors.initials: H
authors.lastname: Goldschmidt
authors.forename: Jose A
authors.initials: JA
authors.lastname: Perez-Simon
authors.forename: Mark
authors.initials: M
authors.lastname: Zijlmans
authors.forename: Reinier A
authors.initials: RA
authors.lastname: Raymakers
authors.forename: Vittorio
authors.initials: V
authors.lastname: Montefusco
authors.forename: Francis A
authors.initials: FA
authors.lastname: Ayuk
authors.forename: Marinus H J
authors.initials: MH
authors.lastname: van Oers
authors.forename: Arnon
authors.initials: A
authors.lastname: Nagler
authors.forename: Leo F
authors.initials: LF
authors.lastname: Verdonck
authors.forename: Henk M
authors.initials: HM
authors.lastname: Lokhorst
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001897:Boronic Acids / Q000008:administration & dosage*; D000069286:Bortezomib; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D017710:Lymphocyte Transfusion; D008297:Male; D009101:Multiple Myeloma / Q000150:complications / Q000628:therapy*; D011719:Pyrazines / Q000008:administration & dosage*; D012074:Remission Induction; D033581:Stem Cell Transplantation; D013792:Thalidomide / Q000008:administration & dosage*; D014184:Transplantation, Homologous
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D007166:Immunosuppressive Agents; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib